Clinical Trials Logo

Clinical Trial Summary

The investigators are studying the initial autonomic alterations in participants recently diagnosed with DM2 and in those patients classified as Pre-Diabetes, mainly focused on the baroreceptor sensitivity and on the peripheral sympathetic innervation.


Clinical Trial Description

Until now the autonomic dysfunction in Diabetes Mellitus type 2 (DM2)has been broadly studied in long term patients. Thus, clinical features as cardiac autonomic neuropathy (CAN) and the lack of the baroreceptor reflex were widely described in patients with a long standing Diabetes. However, there hasn´t been a description of the initial autonomic imbalance in both Pre-Diabetes and recently diagnosed DM2 patients. This is the goal of the present research study, to assess the autonomic dysfunction among these sets of patients.

Yet CAN is finding mostly happening in late stages of DM2 and so the lack of Baroreceptor reflex sensitivity there are other subtle indicators of dysautonomia which hasn't been extensively analyzed. In fact, rest tachycardia and orthostatic intolerance may point to an early dysautonomia. A description of the impairment of the cardiovascular autonomic regulation is still missing. Therefore, the investigators intend to evaluate this regulation through the means of a Task Force System. ;


Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT02931773
Study type Observational
Source Instituto Nacional de Cardiologia Ignacio Chavez
Contact Manuel A Sierra-Beltrán, Dr
Phone 00525556557059
Email manuel.sierra-beltran96@alumni.imperial.ac.uk
Status Recruiting
Phase N/A
Start date August 2016
Completion date December 2017

See also
  Status Clinical Trial Phase
Completed NCT05812209 - Stellate Ganglion Block to Treat Long COVID 19 Case Series
Completed NCT00565526 - Evaluation of the Role of the Autonomic Nervous System in Sj(SqrRoot)(Delta)Gren s Syndrome
Recruiting NCT05741112 - The Long COVID-19 Wearable Device Study N/A
Active, not recruiting NCT05630040 - VNS for Long-COVID-19 N/A
Completed NCT03185247 - Implementation of Transdx Group for POTS N/A
Completed NCT01367977 - Head Circumference Growth in Children With Ehlers-Danlos Syndrome Who Develop Dysautonomia Later in Life
Recruiting NCT05041387 - Data Collection of Standard Care of Patients in the EMG Section
Terminated NCT00221689 - Intrathecal Baclofen Therapy and Paroxysmal Dysautonomia in Severe Brain-Injured Patients Phase 2
Recruiting NCT05681455 - Physiotherapy for Persistent Function by Superficial Neuromodulation N/A
Withdrawn NCT01343329 - Controlling Hyperadrenergic Activity in Neurologic Injury Phase 1/Phase 2
Active, not recruiting NCT05638620 - Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID Phase 1
Not yet recruiting NCT06073886 - Personalized Brain Stimulation to Treat Chronic Concussive Symptoms Phase 2
Completed NCT03674541 - The Exercise Response to Pharmacologic Cholinergic Stimulation in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome Phase 2
Recruiting NCT05566379 - Mindfulness in Post Acute Sequelae of SARS-CoV-2 Infection (PASC) Dysautonomia N/A
Recruiting NCT05855356 - Post Covid-19 Dysautonomia Rehabilitation Randomized Controlled Trial N/A
Completed NCT04121338 - Temporary Celiac Ganglion Block as a Test Before Celiac Ganglion Resection for Dysautonomia-Related Bowel Dysmotility Phase 1
Recruiting NCT05400174 - Blood Pressure Effects on Cognition and Brain Blood Flow in PD N/A
Completed NCT01692561 - MRI to Assess the Effects of Dysautonomia and Chronic Nausea on Brain Transmitters
Not yet recruiting NCT04502199 - Dysautonomic Phenotype in Male Patients With MECP2 Mutation
Active, not recruiting NCT05515640 - Dysautonomia and Systemic Interactions in Traumatic Brain Injury